The trademark TELOMERE THERAPEUTICS was filed by TELOMERE THERAPEUTICS S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on August 2, 2021, and received one opposition filed on October 4, 2021 by MONTEPELAYO, S.L.U. on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by González-Mogena González, Iñigo A.
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical products for the diagnosis and treatment of ageing-related diseases
Pharmaceutical products for the diagnosis and treatment of syndromes and diseases associated with telomere shortening
Pharmaceutical products for the diagnosis and treatment of pulmonary fibrosis, kidney fibrosis, aplastic anemia and dyskeratosis congenita
Reagents, biomarkers and compounds for the diagnosis and treatment of ageing-related diseases
Reagents, biomarkers and compounds for the diagnosis and treatment of syndromes and diseases associated with telomere shortening
Reagents, biomarkers and compounds for the diagnosis and treatment of pulmonary fibrosis, kidney fibrosis, aplastic anemia and dyskeratosis congenita.
The mark was filed in class 10 with following description of goods:
Medical devices and apparatus for the diagnosis and treatment of ageing-related diseases
Medical devices and apparatus for the diagnosis and treatment of syndromes and diseases associated with telomere shortening
Medical devices and apparatus for the diagnosis and treatment of pulmonary fibrosis, kidney fibrosis, aplastic anemia and dyskeratosis congenita
Tools for medical diagnostics in the field of ageing-related diseases
Medical therapy instruments for use in the field of ageing-related diseases.
The mark was filed in class 35 with following description of goods:
Import, export, retailing and wholesaling of pharmaceutical products, reagents, biomarkers, compounds and medical devices for the diagnosis and treatment of ageing-related diseases
Import, export, retailing and wholesaling of pharmaceutical products, reagents, biomarkers, compounds and medical devices for the diagnosis and treatment of syndromes and diseases associated with telomere shortening
Import, export, retailing and wholesaling of pharmaceutical products, reagents, biomarkers, compounds and medical devices for the diagnosis and treatment of pulmonary fibrosis, kidney fibrosis, aplastic anemia and dyskeratosis congenita
Commercial administration of the licensing of pharmaceutical products, reagents, biomarkers, compounds and medical devices for the diagnosis and treatment of ageing-related diseases
Commercial administration of the licensing of pharmaceutical products, reagents, biomarkers, compounds and medical devices for the diagnosis and treatment of syndromes and diseases associated with telomere shortening
Commercial administration of the licensing of pharmaceutical products and medical devices for the diagnosis and treatment of pulmonary fibrosis, kidney fibrosis, aplastic anemia and dyskeratosis congenita.
The mark was filed in class 42 with following description of goods:
Research and development in the field of biotechnology
Research in the field of gene therapy
Biotechnological research in the field of gene therapy and ageing-related diseases
Design and development of pharmaceutical products, medical devices, reagents, biomarkers and compounds for the diagnosis and treatment of ageing-related diseases
Design and development of pharmaceutical products, medical devices, reagents, biomarkers and compounds for the diagnosis and treatment of syndromes and diseases associated with telomere shortening
Design and development of pharmaceutical products, medical devices, reagents, biomarkers and compounds for the diagnosis and treatment of pulmonary fibrosis, kidney fibrosis, aplastic anemia and dyskeratosis congenita
Clinical trials of pharmaceutical products, reagents, biomarkers and compounds for the diagnosis and treatment of ageing-related diseases
Clinical trials of pharmaceutical products, reagents, biomarkers and compounds for the diagnosis and treatment of syndromes and diseases associated with telomere shortening
Clinical trials of pharmaceutical products, reagents, biomarkers and compounds for the diagnosis and treatment of pulmonary fibrosis, kidney fibrosis, aplastic anemia and dyskeratoris congenita.